Ciclopirox Olamine (Perrigo New York Inc)
Welcome to the PulseAid listing for the Ciclopirox Olamine drug offered from Perrigo New York Inc. This Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
NON-PROPRIETARY NAME: | Ciclopirox Olamine |
SUBSTANCE NAME: | CICLOPIROX OLAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2006-12-29 |
END MARKETING DATE: | 0000-00-00 |
Ciclopirox Olamine HUMAN PRESCRIPTION DRUG Details:
Item Description | Ciclopirox Olamine from Perrigo New York Inc |
LABELER NAME: | Perrigo New York Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 7.7(mg/100mL) |
START MARKETING DATE: | 2006-12-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45802-400_dbd4f19e-c345-4862-9d92-831d052d02bf |
PRODUCT NDC: | 45802-400 |
APPLICATION NUMBER: | ANDA077676 |
Other CICLOPIROX OLAMINE Pharmaceutical Manufacturers / Labelers: